These findings indicate that Lgr5+ liver stem cells are crucial for recovery from liver dysfunction, and that the combination of HGF and Rspo1, which induces Lgr5+ stem cells, might be able to be used for liver fibrosis therapy. The gene discussed is HGF; the disease is Hepatic fibrosis.